Related Experiment Video
Updated: Mar 15, 2026

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
Published on: May 5, 2023
CRISPR/Cas9 Genome Editing as a Strategy to Study the Tumor Microenvironment in Transgenic Mice
1GCRC Transgenic Facility, Department of Human Genetics, Goodman Cancer Research Centre, McGill University, 1160 Pine Avenue West, rm419, Montreal, QC, Canada, H3A1A3. yojiro.yamanaka@mcgill.ca.
Abstract:
Development of engineered site-specific endonucleases like zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas9 has been revolutionizing genetic approaches in biomedical research fields. These new tools have opened opportunities to carry out targeted genome editing in mouse zygotes without the need for manipulating embryonic stem cells, which have a higher technical burden and many constraints in strain availability. Specific genetic modifications can be directly generated in working genetic backgrounds. This new approach saves time and costs associated with generation and backcrossing of genetically modified animals and will facilitate their use in various cancer research fields.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis
CRISPR/Cas9 Genome Editing
CRISPR

